Degree in Business Administration and MBA from ESADE, Master CEMS (Community of European Management Schools) in Management from HEC – Hautes Études Commerciales (París) and Chartered Financial Analyst (CFA).
Founder Partner of Invivo Partners, focused on early-stage investments in the healthcare sector.
He serves or has served on the Board of Directors of many life sciences companies including Sanifit (acquired by Vifor), Versantis (acquired by Genfit), Peptomyc and Glycardial Diagnostics, Arthex, Pulmobiotics, Gyala, Telum, OneChain and Telomere Therapeutics.
Involved in the Spanish VC industry for the past 20 years with a focus on high-growth, early stage, technology centered investments.
Previously, he led Spinnaker Invest, VC fund within Grupo Financiero Riva y García. He has been as well a member of the Board of Directors of various companies such as Exoticca, Wecare-u and Scytl.